See also this year's filing and all EDGAR filings for this company.
PDF Report 0001633932_2022_ESSA_Pharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001633932')"} |
Graph
Absolute values for 0001633932, ESSA Pharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 197,598,077 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 567,741 |
4 | LiabilitiesCurrent | 3,929,663 |
5 | LiabilitiesNoncurrent | 210,251 |
6 | remainder_Liabilities | 20,352 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,884,581 |
9 | ResearchAndDevelopmentExpense | 24,258,989 |
10 | remainder_Expenses | -12,129 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 325,980 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 198,165,818 |
1 | Liabilities | 4,160,266 |
2 | Expenses | 37,131,441 |
3 | Revenues | 0 |
4 | StockholdersEquity | 194,005,552 |
5 | NetIncome | -36,805,461 |
6 | ComprehensiveNetIncome | -36,805,461 |
7 | BaseVar | 119,891,752 |
8 | EconomicCapitalRatio | 2.93 |